Literature DB >> 16519265

Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: verbal versus design fluency.

Wes S Houston1, Dean C Delis, Amy Lansing, Mark W Jacobson, Krystal R Cobell, David P Salmon, Mark W Bondi.   

Abstract

Recent studies have reported cognitive asymmetries in patients with Alzheimer's disease (AD) and in individuals with apolipoprotein E epsilon4 (APOE epsilon4) genotype who are in the preclinical phase of AD. This increased frequpncy of cognitive asymmetry, typically defined as a significant discrepancy (in either direction) between verbal and spatial abilities, often occurs despite an absence of differences on traditional measures of central tendency (i.e., mean test scores). We prospectively studied the relationship between APOE genotype and two modality-specific executive-function tasks: The Verbal Fluency and Design Fluency tests of the Delis-Kaplan Executive Function System (D-KEFS) in 52 normal functioning older adult participants who were grouped according to the presence (n=24) or absence (n=28) of the APOE e4 allele. Nondemented older adults with the APOE epsilon4 allele demonstrated a greater frequency of cognitive asymmetric profile on the new switching conditions of the Verbal and Design Fluency measures than the APOE non-epsilon4 individuals. This study further supports the utility of assessing cognitive asymmetry for the detection of subtle cognitive differences in individuals at-risk for AD, and suggests that dual-task executive function tests (i.e., fluency plus switching) may serve as a useful preclinical marker of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16519265     DOI: 10.1017/s1355617705051015

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  19 in total

1.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.

Authors:  Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2011-12-08       Impact factor: 3.445

Review 2.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 3.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

4.  APOE epsilon4 and the cognitive genetics of multiple sclerosis.

Authors:  O Ghaffar; M Reis; N Pennell; P O'Connor; A Feinstein
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

5.  Neural systems supporting lexical search guided by letter and semantic category cues: a self-paced overt response fMRI study of verbal fluency.

Authors:  Rasmus M Birn; Lauren Kenworthy; Laura Case; Rachel Caravella; Tyler B Jones; Peter A Bandettini; Alex Martin
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

6.  Normative Data for Derived Measures and Discrepancy Scores for the Uniform Data Set 3.0 Neuropsychological Battery.

Authors:  Paulina V Devora; Samantha Beevers; Andrew M Kiselica; Jared F Benge
Journal:  Arch Clin Neuropsychol       Date:  2019-01-24       Impact factor: 2.813

7.  Frontal brain asymmetry in depression with comorbid anxiety: a neuropsychological investigation.

Authors:  Brady D Nelson; Casey Sarapas; E Jenna Robison-Andrew; Sarah E Altman; Miranda L Campbell; Stewart A Shankman
Journal:  J Abnorm Psychol       Date:  2012-03-19

Review 8.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

9.  Brain atrophy associated with baseline and longitudinal measures of cognition.

Authors:  V A Cardenas; L L Chao; C Studholme; K Yaffe; B L Miller; C Madison; S T Buckley; D Mungas; N Schuff; M W Weiner
Journal:  Neurobiol Aging       Date:  2009-05-14       Impact factor: 4.673

Review 10.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.